Harmonium International Inc. has sold a minority stake to Lallemand
November 2011 — Laboratories Stand has sold a minority sake in Harmonium International Inc. to Lallemand for US$30 million.
Lallemand is a global leader in the development, production and marketing of yeast, bacteria and specialty ingredients.
Laboratoires Standa develops and commercializes products which maintain the original quality of food products (ATCO and SANICO ranges) and brings under control the fermentation of dairy products.
Our role in the transaction
Oaklins' team in Montreal, Canada, acted as the exclusive advisor to the seller in this transaction.
Contacter l'équipe de la transaction
Transactions connexes
KPS Food Group has joined ForFarmers Polska, a joint venture controlled by ForFarmers N.V.
ForFarmers N.V. has strengthened its position in Poland’s growing poultry market through the establishment of a joint venture with KPS Food Group, a leading poultry producer with operations spanning farming, slaughtering and food processing. ForFarmers’ existing Polish joint venture, Tasomix, and KPS’s operations have been combined to form ForFarmers Polska, which has an enterprise value of approximately US$585 million. ForFarmers holds a controlling 50.5% stake and will fully consolidate the joint venture. The founders of KPS and Tasomix remain minority shareholders.
En apprendre plusKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
En apprendre plusTandem has completed a voluntary public tender offer for the shares of Compagnia dei Caraibi
Tandem S.r.l. has completed a voluntary public tender offer for 25.99% of the shares in Compagnia dei Caraibi S.p.A.
En apprendre plus